Evidence map›Paper›PMID 38823415›Full record

ArticleThe veterinary quarterly2024

Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses.

Guk-Il Joung, Jeong-Yeol Bae, Jung-Il Kim, Jin-Young Kim, Joong-Hyun Song

Abstract read
In one paragraph

Article in The veterinary quarterly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guk-Il JoungDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.
Jeong-Yeol BaeDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.
Jung-Il KimDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.
Jin-Young KimDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.
Joong-Hyun SongDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dogs that had splenectomy are predisposed to fatal thrombotic conditions, and thrombocytosis is a risk factor for post-splenectomy hypercoagulability. However, in veterinary medicine, there are no specific therapeutic approaches for managing this hypercoagulability. This study aimed to determine the preventive effect of clopidogrel on post-operative hypercoagulability during the first 2 weeks post-splenectomy in dogs with splenic masses. This study included 12 dogs that had splenectomy. Seven dogs received no treatment (group A), and five were treated with clopidogrel (group B). Clopidogrel was loaded at 10 mg/kg on day 2 and continued at 2 mg/kg until day 14. Blood samples were collected on the day of surgery and 2, 7, and 14 days after splenectomy in both groups. In group B, thromboelastography (TEG) was performed on the same days. In group A, there was significant elevation of platelet counts on days 7 (

Indexed as

ClopidogrelDog DiseasesPlatelet Aggregation InhibitorsSplenectomyThrombelastographyThrombophiliaAnimalsDogsFemaleMalePlatelet CountPostoperative ComplicationsSplenic DiseasesSplenic NeoplasmsThrombocytosisClopidogrelPlatelet Aggregation InhibitorsClopidogreldoghypercoagulabilitysplenectomythrombocytosis

Identifiers

PMID38823415
PMCPMC11146242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.